Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Merck's share price for the quarter that ended in Jun. 2023 was $115.39. Merck's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 2,539 Mil. Therefore, Merck's market cap for the quarter that ended in Jun. 2023 was $293,025 Mil.
Merck's quarterly market cap
declined
from Dec. 2022 ($281,572 Mil) to Mar. 2023 ($269,959 Mil) but then
increased
from Mar. 2023 ($269,959 Mil) to Jun. 2023 ($293,025 Mil).
Merck's annual market cap
declined
from Dec. 2020 ($197,354 Mil) to Dec. 2021 ($193,715 Mil) but then
increased
from Dec. 2021 ($193,715 Mil) to Dec. 2022 ($281,572 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Merck's Enterprise Value for Today is $288,777 Mil.
Merck Market Cap Historical Data
The historical data trend for Merck's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Merck Annual Data
Trend
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Market Cap
188,891.07
220,191.94
197,353.89
193,715.26
281,572.24
Merck Quarterly Data
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Market Cap
230,952.76
218,177.27
281,572.24
269,959.31
293,024.83
Competitive Comparison
For the Drug Manufacturers - General subindustry, Merck's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck Market Cap Distribution
For the Drug Manufacturers industry and Healthcare sector, Merck's Market Cap distribution charts can be found below:
* The bar in red indicates where Merck's Market Cap falls into.
Merck Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Merck's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck (NYSE:MRK) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Merck Market Cap Related Terms
Thank you for viewing the detailed overview of Merck's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
0.4(0.39%) Volume: 5,872,929 11:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
MRK has been successfully added to your 
